Etentamig is a bispecific T-cell engager (BiTE) targeting both B-cell maturation antigen (BCMA) and the CD3 complex on T cells. This dual specificity enables Etentamig to simultaneously inhibit BCMA activity and activate the CD3 signaling pathway in T cells. It is primarily utilized in research focused on multiple myeloma and immunoglobulin light chain amyloidosis, with potential applications in exploring its effects on cardiovascular diseases. This makes Etentamig a valuable tool for advancing understanding of disease mechanisms and therapeutic strategies in these areas.
Etentamig is a bispecific T-cell engager (BiTE) targeting both B-cell maturation antigen (BCMA) and the CD3 complex on T cells. This dual specificity enables Etentamig to simultaneously inhibit BCMA activity and activate the CD3 signaling pathway in T cells. It is primarily utilized in research focused on multiple myeloma and immunoglobulin light chain amyloidosis, with potential applications in exploring its effects on cardiovascular diseases. This makes Etentamig a valuable tool for advancing understanding of disease mechanisms and therapeutic strategies in these areas.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
